T-TYPE CALCIUM CHANNEL BLOCKER ATTENUATES RENAL FIBROSIS IN MICE WITH UNILATERAL URETERAL OBSTRUCTIVE NEPHROPATHY VIA ACTIVATION OF THE NRF2 ANTIOXIDANT PATHWAY

被引：0
|
作者：
Chung, Sungjin [1 ]
Kim, Soo Jeong [2 ]
Koh, Eun Sil [1 ]
Kim, Sung Jun [3 ]
Kim, Hyung Wook [4 ]
Chang, Yoon Sik [1 ]
Shin, Seok Joon [3 ]
机构：
[1] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Internal Med, Seoul, South Korea
[2] Catholic Univ Korea, Deparment Biomed Sci, Grad Sch, Seoul, South Korea
[3] Catholic Univ Korea, Incheon St Marys Hosp, Dept Internal Med, Inchon, South Korea
[4] Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Suwon, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv174.13
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP278
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pentamethylquercetin Attenuates Cardiac Remodeling via Activation of the Sestrins/Keap1/Nrf2 Pathway in MSG-Induced Obese Mice
    Du, Jingxia
    He, Wei
    Zhang, Cai
    Wu, Jianzhao
    Li, Zhi
    Wang, Min
    Feng, Shuying
    Liang, Gaofeng
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [22] L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway
    Dare, Ayobami
    Channa, Mahendra L.
    Nadar, Anand
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [23] Sevoflurane preconditioning prevents acute renal injury caused by ischemia-reperfusion in mice via activation of the Nrf2 signaling pathway
    Wang, Wen-Xi
    Zhao, Zhen-Ru
    Bai, Ying
    Li, Ya-Xing
    Gao, Xiao-Ning
    Zhang, Sen
    Sun, Yan-Bin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (04)
  • [24] Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway via Up-Regulating Sirt1
    Zhang, Lei
    Chen, Zhiquan
    Gong, Wenyan
    Zou, Yezi
    Xu, Futian
    Chen, Lihao
    Huang, Heqing
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [25] Protective Effects of Efonidipine, a T and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy
    Sasaki, Hidehisa
    Saiki, Atsuhito
    Endo, Kei
    Ban, Noriko
    Yamaguchi, Takashi
    Kawana, Hidetoshi
    Nagayama, Daizi
    Ohhira, Masahiro
    Oyama, Tomokazu
    Miyashita, Yoh
    Shirai, Kohji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (05) : 568 - 575
  • [26] Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-B and Nrf2/HO-1 Signalling Pathway Regulation
    Wang, Yanqiu
    Wang, Bowen
    Du, Feng
    Su, Xuesong
    Sun, Guangping
    Zhou, Guangyu
    Bian, Xiaohui
    Liu, Na
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (03) : 164 - 172
  • [27] Low dose T-TYPE calcium channel blocker efonidipine reduced renal vascular fibrosis and inflammations by TGF-β1 inhibition in prolonged L-name/SHR
    Kameda, Tomoko
    Ono, Hidehiko
    Akashiba, Akira
    Takahashi, Toshiaki
    Ono, Yuko
    Ishimitsu, Toshihiko
    Matsuoka, Hiroaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 343 - 343
  • [28] Bisdemethoxycurcumin Attenuated Renal Injury via Activation of Keap1/Nrf2 Pathway in High-Fat Diet-Fed Mice
    Ding, Xiaoqin
    Chen, Yan
    Zhou, Lina
    Wu, Ruoyun
    Jian, Tunyu
    Lyu, Han
    Liu, Yan
    Chen, Jian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [29] Ezetimibe ketone protects against renal ischemia-reperfusion injury and attenuates oxidative stress via activation of the Nrf2/HO-1 signaling pathway
    Chen, Zhen
    Wang, Kai
    He, Xiaozhou
    Xue, Dong
    Ma, Xuyi
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2024, 38 (08)
  • [30] Aldehyde dehydrogenase 2 activation ameliorates CCl4-induced chronic liver fibrosis in mice by up-regulating Nrf2/HO-1 antioxidant pathway
    Ma, Xin
    Luo, Qin
    Zhu, Hong
    Liu, Xuejing
    Dong, Zhen
    Zhang, Kaili
    Zou, Yunzeng
    Wu, Jian
    Ge, Junbo
    Sun, Aijun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (08) : 3965 - 3978
12345